Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ArthriVarx is an over-the-counter nutritional supplement developed by Innovus Pharmaceuticals to support joint health and alleviate symptoms associated with arthritis, such as pain, stiffness, and inflammation. The formulation combines *Andrographis paniculata*, an herbal extract known for its anti-inflammatory and antioxidant properties, with hyaluronic acid, a glycosaminoglycan that aids in joint lubrication and moisture retention in connective tissues. The supplement works by suppressing key inflammatory mediators, including interferon-gamma, interleukin-2, and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB). It is primarily marketed for individuals seeking to improve joint mobility and manage cartilage damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ArthriVarx.